Tag: Brazil

Bullying the Boss? Compulsory Licensing for Antiretroviral Drugs in Brazil and Thailand

| October 21, 2011 | 0 Comments
Bullying the Boss? Compulsory Licensing for Antiretroviral Drugs in Brazil and Thailand

By Shaira Bhanji Global Health Finance Columnist Underdeveloped, HIV-burdened regions of the world have the potential to make strides toward better survival outcomes, but they lack key resources. Simple antiretroviral drugs such as Efavirenz and Kaletra have been shown to lower deaths from HIV/AIDS by as much as 84 percent, yet the prices of these […]

Continue Reading